Drug Shortage Report for ONDANSETRON ODT
Report ID | 145004 |
Drug Identification Number | 02481731 |
Brand name | ONDANSETRON ODT |
Common or Proper name | ONDANSETRON ODT |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 8MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 10 ODT |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-08-30 |
Estimated end date | 2021-10-15 |
Actual end date | 2021-10-19 |
Shortage status | Resolved |
Updated date | 2021-10-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-10-20 | English | Compare |
v8 | 2021-10-19 | French | Compare |
v7 | 2021-10-19 | English | Compare |
v6 | 2021-10-04 | French | Compare |
v5 | 2021-10-04 | English | Compare |
v4 | 2021-09-20 | French | Compare |
v3 | 2021-09-20 | English | Compare |
v2 | 2021-09-02 | French | Compare |
v1 | 2021-09-02 | English | Compare |
Showing 1 to 9 of 9